allcancercure.com

Walking half an hour every day can help people lose weight and inches of their waistline, reducing their risk of Type 2 diabetes. Researchers at the Duke University Medical Centre, USA, studied the effects of different amounts and intensity of physical activity on 171 middle-aged overweight people over an eight month period. At the start, [...]

It’s been a busy year at Diabetes UK. Highlights of our activities have included our Annual Professional Conference (APC), and exciting new corporate partnerships. We have also run the Measure Up awareness campaign, and undertaken groundbreaking research. And we have been part of an innovative new care project and the World Diabetes Day celebrations. APC [...]

Oculus Innovative Sciences, Inc. (NASDAQ:OCLS) announced completion of enrollment of its Phase II clinical trial of Microcyn® Technology. The company has enrolled and randomized 67 patients in its open-label Phase II clinical trial evaluating its Microcyn Technology in the treatment of mildly infected diabetic foot ulcers. The study, which is being conducted at 15 U.S. [...]

Diabetes development company Dia-B Tech Limited (ASX:DIA) announced that based on very encouraging completed Phase I clinical results of its novel drug ISF402, for the treatment of type 2 diabetes, it will commence planning for the Phase II stage of clinical development. Dia-B has previously announced: – an excellent tolerability profile for ISF402 in humans [...]

The University of Miami Department of Dermatology announced it is recruiting patients with lower extremity diabetic foot ulcers to participate in the MATRIX clinical trial. The MATRIX trial will study the effects of Excellarate™ (GAM501) (Ad5PDGF-B/bovine Type I collagen gel) for the potential treatment of patients with neuropathic non-healing diabetic foot ulcers. Excellarate is an [...]

Clal Biotechnology Industries Ltd., (TASE: CBI), an investment group in the field of life sciences, announced recently that Andromeda Biotech Ltd., a wholly owned subsidiary of CBI, signed a Term Sheet with Teva to develop and commercialize DiaPep277, an innovative and advanced drug for the treatment of type 1 diabetes. According to the Term Sheet, [...]

The Canadian Diabetes Association applauded the Government of Ontario’s commitment to tackle diabetes in Ontario, as outlined in the Speech from the Throne. “The Canadian Diabetes Association is pleased that the Government of Ontario understands the seriousness of diabetes and its complications,” said Karen Philp, Vice President, Public Policy and Government Relations, Canadian Diabetes Association. [...]

People with diabetes will still have access to animal insulin once Novo Nordisk withdraws its pork (porcine) insulins this December. Wockhardt UK says it will continue to supply Hypurin porcine and bovine insulin, giving people with diabetes a much-needed choice of treatment. Cathy Moulton, Diabetes UK care advisor , maintains that it is important for [...]

New research has found that cholesterol drug fenofibrate reduces the risk of diabetic retinopathy, one of the leading causes of blindness. Researchers from the University of Sydney say the drug, which is traditionally used to treat cholesterol, could save the eyesight of many people with diabetes. Patients who took the daily treatment cut their risk [...]

UCB announced that the U.S. Food and Drug Administration (FDA) has accepted for filing the New Drug Application (NDA) for the use of lacosamide in the treatment of diabetic neuropathic pain. The application relates to the tablet formulation of lacosamide, whose proposed trade name is Vimpat(TM). “The fact that a high proportion of patients with [...]